Maurits' practice focuses on helping clients navigate the complex web of EU and member state rules and procedures with an emphasis on food, drugs, medical devices, cosmetics and biotechnology. He helps corporate clients and trade associations shape future legislation and advises on the complex legal issues of the current regulations in areas such as pharmacovigilance (drug safety), clinical trials, marketing authorisations, advertising and promotional issues, labeling and the application of the precautionary principle.
Maurits also advises clients on a broad range of market access and product safety issues such as GMP compliance, life-cycle management, product recall procedures, adverse events, health claims, in-vitro diagnostics, implantable medical devices, food additives, parallel trade and supply chain management. He also advises on pharmaceutical contractual issues, including distribution, supply, manufacturing, R&D and other cooperation agreements in Europe. He has represented clients in matters before the European Commission, the European Medicines Agency, the European Food Safety Authority and member state authorities.
In addition to EU life sciences regulatory issues, Maurits also advises on EU regulatory issues involving chemicals and the environment. He helps clients conduct risk assessments and advises on anti-corruption compliance and government enforcement, including FCPA investigations.
Maurits graduated from the University of Michigan, the University of Leiden (The Netherlands), and the Johns Hopkins Paul H Nitze School of Advanced International Studies (SAIS).
This biography is an extract from The International Who's Who of Life Sciences Lawyers which can be purchased from our Shop.
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.